Changeflow GovPing Healthcare & Life Sciences Patent EP4306150A1 Published - Sanofi Stopper D...
Routine Rule Added Final

Patent EP4306150A1 Published - Sanofi Stopper Device

Favicon for changeflow.com EPO Patent Bulletin - Medical Devices (A61M)
Published
Detected
Email

Summary

The European Patent Office published EP4306150A1 on April 15, 2026, granting Sanofi a patent for a stopper device (IPC classification A61M 5/315). The patent names Bernd Kuehn as the sole inventor and designates 41 contracting states across Europe including DE, FR, GB, IT, ES, NL, and others. This is a routine IP grant event with no compliance obligations imposed on third parties.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Medical Devices (A61M) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 66 changes logged to date.

What changed

The European Patent Office published European Patent EP4306150A1 for Sanofi, covering a stopper device classified under A61M 5/315. The patent names Bernd Kuehn as the sole inventor. The EPO designated 41 contracting states covering the major European markets.

Affected parties in the pharmaceutical and medical device sectors should note that this patent grants Sanofi exclusive rights to the disclosed stopper device technology in the designated EPC contracting states. Parties developing similar stopper devices for medical applications should conduct freedom-to-operate analyses to assess potential infringement risks.

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

STOPPER

Publication EP4306150A1 Kind: A1 Apr 15, 2026

Applicants

SANOFI

Inventors

KUEHN, Bernd

IPC Classifications

A61M 5/315 20060101AFI20231110BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Parties

Get daily alerts for EPO Patent Bulletin - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4306150A1

Who this affects

Applies to
Pharmaceutical companies Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent publication IP grant
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when EPO Patent Bulletin - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!